This VIAF Cluster has been deleted. It is no longer part of VIAF.
Chris Orvig
Orvig, Chris
VIAF ID: 242894937 ( Unknown Name Type )
Permalink: http://viaf.org/viaf/242894937
Preferred Forms
- 100 0 _ ‡a Chris Orvig
- 100 1 _ ‡a Orvig, Chris
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Evaluation of the Tetrakis(3-Hydroxy-4-Pyridinone) Ligand THPN with Zirconium(IV): Thermodynamic Solution Studies, Bifunctionalization, and in Vivo Assessment of Macromolecular 89Zr-THPN-Conjugates | |
Evidence for energy-dependent transport of aluminum out of brain extracellular fluid. | |
Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimer's disease. | |
Frontiers in radionuclide imaging and therapy, a chemical journey from naturally radioactive elements to targeted theranostic agents. | |
Functionally Versatile and Highly Stable Chelator for 111In and 177Lu: Proof-of-Principle Prostate-Specific Membrane Antigen Targeting | |
General method for the synthesis of trishydroxamic acids | |
Glucosamine conjugates bearing N,N,O-donors: potential imaging agents utilizing the [M(CO)3]+ core (M = Re, Tc). | |
A glucosamine-dipicolylamine conjugate of 99mTc(I) and 186Re(I) for use in imaging and therapy. | |
Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy. | |
H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu | |
H2CHXdedpa and H4CHXoctapa—Chiral Acyclic Chelating Ligands for 67/68Ga and 111In Radiopharmaceuticals | |
H2CHXhox: Rigid Cyclohexane-Reinforced Nonmacrocyclic Chelating Ligand for [nat/67/68Ga]Ga3 | |
H4octapa: synthesis, solution equilibria and complexes with useful radiopharmaceutical metal ions. | |
H4octox: Versatile Bimodal Octadentate Acyclic Chelating Ligand for Medicinal Inorganic Chemistry | |
Harnessing the bone-seeking ability of Ca(II)-like metal ions in the treatment of metastatic cancer and resorption disorders. | |
Highly Symmetric Group 13 Metal−Phosphinato Complexes: Multinuclear NMR (27Al,31P,71Ga) Determination of Stability Constants at Low pH | |
Homotrinuclear Lanthanide(III) Arrays: Assembly of and Conversion from Mononuclear and Dinuclear Units† | |
In silico to in vitro screening of hydroxypyridinones as acetylcholinesterase inhibitors. | |
In vitro and in vivo anti-tumor activity of two gold(III) complexes with isoquinoline derivatives as ligands | |
In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease. | |
In vitro studies of lanthanide complexes for the treatment of osteoporosis. | |
In Vivo Electron Spin−Echo Envelope Modulation (ESEEM) Spectroscopy: First Observation of Vanadyl Coordination to Phosphate in Bone | |
Increased potency of vanadium using organic ligands. | |
Influence of Chelation and Oxidation State on Vanadium Bioavailability, and Their Effects on Tissue Concentrations of Zinc, Copper, and Iron | |
Ion Exchange in Hydroxyapatite with Lanthanides | |
Lanthanide chemistry with (bis[[bis(carboxymethyl)amino]methyl]phosphinate: what does an extra phosphinate group do to EDTA? | |
Lanthanide containing compounds for therapeutic care in bone resorption disorders. | |
Lanthanide(iii) and group 13 metal ion complexes of tripodal amino phosphinate ligands | |
Long-chain rhenium and technetium glucosamine conjugates. | |
Metal complexes of maltol and close analogues in medicinal inorganic chemistry. | |
Molecular architectures for trimetallic d/f/d complexes: structural and magnetic properties of a LnNi2 core. | |
N-Aryl-substituted 3-(β-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy | |
[nat/44Sc(pypa)]-: Thermodynamic Stability, Radiolabeling, and Biodistribution of a Prostate-Specific-Membrane-Antigen-Targeting Conjugate | |
New Ga derivatives of the H2dedpa scaffold with improved clearance and persistent heart uptake. | |
New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals | |
Novel "bi-modal" H2dedpa derivatives for radio- and fluorescence imaging. | |
Novel carbohydrate-appended metal complexes for potential use in molecular imaging. | |
Octadentate Oxine-Armed Bispidine Ligand for Radiopharmaceutical Chemistry | |
p-NO2-Bn-H4neunpa and H4neunpa-Trastuzumab: Bifunctional Chelator for Radiometalpharmaceuticals and 111In Immuno-Single Photon Emission Computed Tomography Imaging. | |
A Perspective - can copper complexes be developed as a novel class of therapeutics? | |
Pharmacokinetics of aluminum 3-hydroxypyridin-4-one complexes: implications for aluminum redistribution subsequent to chelation therapy | |
Potential 67Ga radiopharmaceuticals for myocardial imaging: Tris(1-aryl-3-hydroxy-2-methyl-4-pyridinonato)gallium(III) complexes | |
Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies. | |
Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential. | |
Pyridine-tert-nitrogen-phenol ligands: N,N,O-Type tripodal chelates for the [M(CO)3]+ core (M = Re, Tc). | |
Radioactive Main Group and Rare Earth Metals for Imaging and Therapy | |
Rapid Thermodynamically Stable Complex Formation of [nat/111In]In3+, [nat/90Y]Y3+, and [nat/177Lu]Lu3+ with H6dappa | |
Reaction chemistry of BMOV, bis(maltolato)oxovanadium(IV), a potent insulin mimetic agent | |
Reduction of [VO2(ma)2]- and [VO2(ema)2]- by ascorbic acid and glutathione: kinetic studies of pro-drugs for the enhancement of insulin action. | |
[ReO | |
RGD conjugates of the H2dedpa scaffold: synthesis, labeling and imaging with 68Ga. | |
Selectivity among, and aggregation of, lanthanide ions | |
Stan Kirschner—An appreciation | |
Structural characteristics of chloroquine-bridged ferrocenophane analogues of ferroquine may obviate malaria drug-resistance mechanisms. | |
Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications. | |
Synthesis and characterization of lipophilic cationic Ga(iii) complexes based on the H2CHXdedpa and H2dedpa ligands and their 67/68Ga radiolabeling studies | |
Synthesis and insulinomimetic activities of novel mono- and tetranuclear oxovanadium(IV) complexes with 3-hydroxypyridine-2-carboxylic acid. | |
Synthesis and solution studies of the complexes of trivalent lanthanides with the tetraazamacrocycle TETA-(PO)(2). | |
Synthesis, characterization, and evaluation of the antimicrobial potential of copper(II) coordination complexes with quinolone and p-xylenyl-linked quinolone ligands. | |
Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy. | |
Synthesis, structure, and biological activity of ferrocenyl carbohydrate conjugates. | |
tBu4octapa-alkyl-NHS for metalloradiopeptide preparation | |
Theoretical Studies of the Tautomers of Pyridinethiones | |
Unprecedented sugar-dependent in vivo antitumor activity of carbohydrate-pendant cis-diamminedichloroplatinum(II) complexes. | |
Vanadium complexes with mixed O,S anionic ligands derived from maltol: synthesis, characterization, and biological studies. | |
Vanadium in diabetes: 100 years from Phase 0 to Phase I. | |
Vanadium treatment of type 2 diabetes: a view to the future. | |
Vanadyl-thiazolidinedione combination agents for diabetes therapy. | |
Werner coordination chemistry and neurodegeneration. |